These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27473816)

  • 61. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life.
    Eisbruch A; Dawson LA; Kim HM; Bradford CR; Terrell JE; Chepeha DB; Teknos TN; Anzai Y; Marsh LH; Martel MK; Ten Haken RK; Wolf GT; Ship JA
    Acta Otorhinolaryngol Belg; 1999; 53(3):271-5. PubMed ID: 10635407
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma.
    Daly ME; Lieskovsky Y; Pawlicki T; Yau J; Pinto H; Kaplan M; Fee WE; Koong A; Goffinet DR; Xing L; Le QT
    Head Neck; 2007 Mar; 29(3):211-20. PubMed ID: 17111429
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Objective and subjective hyposalivation after treatment for head and neck cancer: Long-term outcomes.
    Likhterov I; Ru M; Ganz C; Urken ML; Chai R; Okay D; Liu J; Stewart R; Culliney B; Palacios D; Lazarus CL
    Laryngoscope; 2018 Dec; 128(12):2732-2739. PubMed ID: 30325025
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma.
    Ahmed M; Hansen VN; Harrington KJ; Nutting CM
    Med Dosim; 2009; 34(3):217-24. PubMed ID: 19647632
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
    Pow EH; Kwong DL; McMillan AS; Wong MC; Sham JS; Leung LH; Leung WK
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):981-91. PubMed ID: 17145528
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impact of radiation dose on patient-reported acute taste alteration in a prospective observational study cohort in head and neck squamous cell cancer (HNSCC).
    Morelli I; Desideri I; Romei A; Scoccimarro E; Caini S; Salvestrini V; Becherini C; Livi L; Bonomo P
    Radiol Med; 2023 Dec; 128(12):1571-1579. PubMed ID: 37642816
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Toxicity, quality of life, and functional outcomes of 176 hypopharyngeal cancer patients treated by (chemo)radiation: the impact of treatment modality and radiation technique.
    Al-Mamgani A; Mehilal R; van Rooij PH; Tans L; Sewnaik A; Levendag PC
    Laryngoscope; 2012 Aug; 122(8):1789-95. PubMed ID: 22833307
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Outcomes of intensity-modulated radiotherapy as primary treatment for oropharyngeal squamous cell carcinoma - a European singleinstitution analysis.
    Bird T; De Felice F; Michaelidou A; Thavaraj S; Jeannon JP; Lyons A; Oakley R; Simo R; Lei M; Guerrero Urbano T
    Clin Otolaryngol; 2017 Feb; 42(1):115-122. PubMed ID: 27185284
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy.
    Scrimger R; Kanji A; Parliament M; Warkentin H; Field C; Jha N; Hanson J
    Am J Clin Oncol; 2007 Jun; 30(3):271-7. PubMed ID: 17551304
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: a matched-pair analysis.
    Al-Mamgani A; Van Rooij P; Tans L; Teguh DN; Levendag PC
    Technol Cancer Res Treat; 2013 Apr; 12(2):123-30. PubMed ID: 23098281
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effect of hyperbaric oxygen therapy on quality of life in oral and oropharyngeal cancer patients treated with radiotherapy.
    Gerlach NL; Barkhuysen R; Kaanders JH; Janssens GO; Sterk W; Merkx MA
    Int J Oral Maxillofac Surg; 2008 Mar; 37(3):255-9. PubMed ID: 18262761
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Role of minor salivary glands in developing patient-rated xerostomia and sticky saliva during day and night.
    Beetz I; Schilstra C; Visink A; van der Schaaf A; Bijl HP; van der Laan BF; Steenbakkers RJ; Langendijk JA
    Radiother Oncol; 2013 Nov; 109(2):311-6. PubMed ID: 23953752
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
    Thorstad WL; Chao KS; Haughey B
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Stricter Postoperative Oropharyngeal Cancer Radiation Therapy Normal Tissue Dose Constraints Are Feasible.
    Su W; Wright CM; Lee DY; Kim M; Anstadt EJ; Teo BK; Carlson DJ; Lukens JN; Eisbruch A; Lin A
    Pract Radiat Oncol; 2022; 12(4):e282-e285. PubMed ID: 35304348
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intensity-modulated radiotherapy followed by a brachytherapy boost for oropharyngeal cancer.
    Al-Mamgani A; Levendag PC; van Rooij P; Meeuwis CA; Sewnaik A; Teguh DN
    Head Neck; 2013 Dec; 35(12):1689-97. PubMed ID: 23483648
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Xerostomia after radiotherapy and its effect on quality of life in head and neck cancer patients.
    Kakoei S; Haghdoost AA; Rad M; Mohammadalizadeh S; Pourdamghan N; Nakhaei M; Bahador M
    Arch Iran Med; 2012 Apr; 15(4):214-8. PubMed ID: 22424038
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Speech and voice outcomes in oropharyngeal cancer and evaluation of the University of Washington Quality of Life speech domain.
    Thomas L; Jones TM; Tandon S; Carding P; Lowe D; Rogers S
    Clin Otolaryngol; 2009 Feb; 34(1):34-42. PubMed ID: 19260883
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessments.
    Lee TF; Chao PJ; Wang HY; Hsu HC; Chang P; Chen WC
    BMC Cancer; 2012 Dec; 12():567. PubMed ID: 23206972
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.
    Ho KF; Marchant T; Moore C; Webster G; Rowbottom C; Penington H; Lee L; Yap B; Sykes A; Slevin N
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e375-82. PubMed ID: 22197229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.